Cory Abate-Shen

Cory Abate-Shen

Columbia University in the City of New York

H-index: 76

North America-United States

About Cory Abate-Shen

Cory Abate-Shen, With an exceptional h-index of 76 and a recent h-index of 35 (since 2020), a distinguished researcher at Columbia University in the City of New York, specializes in the field of cancer biology, transcriptional regulation, developmental biology.

His recent articles reflect a diverse array of research interests and contributions to the field:

In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis

MP16-18 COMBINATION REGIMEN OF INTRAVESICAL DOCETAXEL, GEMCITABINE, AND CISPLATIN IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER

Distinct mesenchymal cell states mediate prostate cancer progression

Metformin Overcomes the Consequences of NKX3. 1 Loss to Suppress Prostate Cancer Progression

Modeling Cancer in Mice

Investigating regulatory drivers of prostate cancer metastasis in circulating tumor cells

Editor's Note: Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer

Abstract IA012: Modeling prostate cancer metastasis in genetically engineered mouse models

Cory Abate-Shen Information

University

Position

___

Citations(all)

25288

Citations(since 2020)

5139

Cited By

21835

hIndex(all)

76

hIndex(since 2020)

35

i10Index(all)

141

i10Index(since 2020)

91

Email

University Profile Page

Columbia University in the City of New York

Google Scholar

View Google Scholar Profile

Cory Abate-Shen Skills & Research Interests

cancer biology

transcriptional regulation

developmental biology

Top articles of Cory Abate-Shen

Title

Journal

Author(s)

Publication Date

In vivo genome-wide CRISPR screening identifies CITED2 as a driver of prostate cancer bone metastasis

Oncogene

Juan M Arriaga

Kacey Ronaldson-Bouchard

Florencia Picech

Francisca Nunes de Almeida

Stephanie Afari

...

2024/3/7

MP16-18 COMBINATION REGIMEN OF INTRAVESICAL DOCETAXEL, GEMCITABINE, AND CISPLATIN IN PATIENTS WITH BCG-UNRESPONSIVE NON-MUSCLE INVASIVE UROTHELIAL CARCINOMA OF THE BLADDER

The Journal of Urology

Benjamin I Joffe

John R Christin

Clémentine Le Coz

Jamie S Pak

Caroline Laplaca

...

2024/5

Distinct mesenchymal cell states mediate prostate cancer progression

Nature Communications

Hubert Pakula

Mohamed Omar

Ryan Carelli

Filippo Pederzoli

Giuseppe Nicolò Fanelli

...

2024/1/8

Metformin Overcomes the Consequences of NKX3. 1 Loss to Suppress Prostate Cancer Progression

European urology

Alexandros Papachristodoulou

Isabel Heidegger

Renu K Virk

Matteo Di Bernardo

Jaime Y Kim

...

2024/4/1

Modeling Cancer in Mice

Laurie Jackson-Grusby

2002/8

Investigating regulatory drivers of prostate cancer metastasis in circulating tumor cells

Cancer Research

Aunika Zheng

Aleksandar Obradovic

Kacey Ronaldson-Bouchard

Gordana Vunjak-Novakovic

Andrea Califano

...

2024/3/22

Editor's Note: Activator Protein-1 Transcription Factors Are Associated with Progression and Recurrence of Prostate Cancer

Cancer Research

Xuesong Ouyang

Walter J Jessen

Hikmat Al-Ahmadie

Angel M Serio

Yong Lin

...

2023/4/4

Abstract IA012: Modeling prostate cancer metastasis in genetically engineered mouse models

Cancer Research

Cory Abate-Shen

Arianna Giacobbe

Aleksandar Obradovic

Alessandro Vasciaveo

Florencia Picech

...

2023/6/2

Identifying neuroendocrine prostate cancer drivers using in vivo forward genetics

Cancer Research

Alessandro Vasciaveo

Francisca Nunes De Almeida

Min Zou

Matteo Di Bernardo

Andrea Califano

...

2023/4/4

KLRG1 marks tumor-infiltrating CD4 T cell subsets associated with immune escape and immunotherapy response

Cancer Research

Casey Ager

Matthew Chaimowitz

Shruti Bansal

Meri Rogava

Johannes Melms

...

2023/4/4

NSD2 maintains lineage plasticity and castration-resistance in neuroendocrine prostate cancer

bioRxiv

Jia J Li

Alessandro Vasciaveo

Dimitrios Karagiannis

Zhen Sun

Xiao Chen

...

2023

Editor's Note: Dual Targeting of the Akt/mTOR Signaling Pathway Inhibits Castration-Resistant Prostate Cancer in a Genetically Engineered Mouse Model

Cancer Research

Nicola Floc'h

Carolyn Waugh Kinkade

Takashi Kobayashi

Alvaro Aytes

Celine Lefebvre

...

2023/4/4

A forward genetic screen identifies SIRT1 as a driver of neuroendocrine prostate cancer

Cancer Research

Francisca Nunes de Almeida

Alessandro Vasciaveo

Min Zou

Matteo Di Bernardo

Andrea Califano

...

2023/4/4

OncoLoop: A network-based precision cancer medicine framework

Cancer discovery

Alessandro Vasciaveo

Juan Martín Arriaga

Francisca Nunes de Almeida

Min Zou

Eugene F Douglass Jr

...

2023/2/6

Prognostic markers of metastatic cancer

2022/9/29

Functional atlas of prostate mesenchyme

Cancer Research

Hubert Pakula

Ryan Carelli

Nicolo Fanelli

Madhavi Jere

Caitlin Unkenholz

...

2022/6/15

NKX3. 1 expression predicts response to metformin intervention in prostate cancer

Cancer Research

Alexandros Papachristodoulou

Aditya Dutta

Cory Abate-Shen

2022/6/15

Establishment of the LNCaP cell line–the dawn of an era for prostate cancer research

Cancer research

Cory Abate-Shen

Francisca Nunes de Almeida

2022/5/3

Precision intervention for prostate cancer: re-evaluating who is at risk

Cancer Letters

Alexandros Papachristodoulou

Cory Abate-Shen

2022/4/29

329 Longitudinal immune profiling reveals unique myeloid and T cell phenotypes associated with spontaneous immunoediting in a novel prostate tumor model

Journal of Clinical and Translational Science

Casey Ager

Aleksandar Obradovic

Juan M Arriaga

Matthew G Chaimowitz

Cory Abate-Shen

...

2022/4

See List of Professors in Cory Abate-Shen University(Columbia University in the City of New York)